Foretinib

response biomarkers — cross-omics
Drug responseDRUG → PROTEIN-RPPACell lineGSK1363089, XL-880, EXEL-2880, GSK089

Across CCLE and GDSC cell-line panels, response to Foretinib is significantly associated with the total protein of multiple proteins, with BLOOD_Lymphoma cell lines showing a particularly strong set of associations.

The most reproducible Foretinib response-associated proteins across cancer lineages are VEGFR2, p70-S6K, and AMPK_alpha, each associated with drug response in up to 7 lineages. Since the analysis identifies associations rather than directional relationships, both response-to-biomarker and biomarker-to-response views are provided.

Each biomarker is linked to its corresponding Q-omics profile. The scatter plot shows the strongest observed association, Foretinib response versus VEGFR2 total protein in BLOOD_Lymphoma (Pearson r = -0.39).

Total protein biomarkers of Foretinib response

Ranked by combined sampling and lineage consensus. X-score (response→biomarker) and Y-score (biomarker→response) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLOOD_LymphomaVEGFR2 →-1.339-0.529.004.00637
KIDNEYp70-S6K →+0.426+0.570.017.00637
LUNG_SCLCAMPK_alpha →-0.467-0.466.008.03536
LIVERC-Raf(BD610151) →+1.030+0.607.005.02435
BREASTmTOR_pS2448 →-0.262-0.706.030<.00135
URINARY_TRACTGSK-3_pS9 →-1.120-0.778.002.00535
Each biomarker links to its Q-omics profile. Showing the 6 strongest associations by consensus.

Foretinib response vs VEGFR2 — BLOOD_Lymphoma

Per-cell-line scatter of Foretinib response vs VEGFR2 total protein in BLOOD_Lymphoma.

Explore this scatter interactively →

Exploration